There are diabetics that need it." Credit: Victor Chavez/Shutterstock
Consequently, a phase 3 trial on ambroxol has been planned and is due to start recruitment in the near future (NCT05778617), a phase 2 trial in GBA-associated PD is ongoing (NCT05287503) [124], and another phase 2 trial on PD dementia is expected to finish in December 2025 (NCT02914366) [125]
For men over 50 with metabolic comorbidities, the cardiovascular and glycemic benefits of GLP-1 treatment may be the most meaningful outcomes, independent of how much weight is lost
Wrong technique (too deep injections into the muscles), too shallow (into the dermis) can limit the effectiveness of the medications
( A - C ) 25 g/L/mouse IgG1 (n=5), 1 g/L/mouse mGIPR-Ab/P3 (n=6), 5 g/L/mouse mGIPR-Ab/P3 (n=6), 10 g/L/mouse mGIPR-Ab/P3 (n=6), or 25 g/L/mouse mGIPR-Ab/P3 (n=6)